Evidence map›Paper›PMID 29439691›Full record

Trial reportBMC public health2018

What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.

Marie-Anne Durand, Renata West Yen, A James O'Malley, Mary C Politi, Shubhada Dhage, Kari Rosenkranz, Katie Weichman, Julie Margenthaler, Anna N A Tosteson, Eloise Crayton and 10 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03136367 (Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03136367 nacompletednot on this map

Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata

TypeinterventionalSponsorDartmouth-Hitchcock Medical CenterRan2017 to 2019Enrolled571ConditionsBreast CancerArmsOption Grid, Picture Option Grid
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Marie-Anne DurandThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA. marie-anne.durand@dartmouth.edu.
Renata West YenThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
A James O'MalleyThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Mary C PolitiDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Shubhada DhageLaura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
Kari RosenkranzDartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Katie WeichmanMontefiore Medical Center, Bronx, NY, USA.
Julie MargenthalerDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Anna N A TostesonThe Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College, and Norris Cotton Cancer Center, Lebanon, NH, USA.
Eloise CraytonDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Sherrill JacksonDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Ann BradleyThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Robert J VolkThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Karen SepuchaDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Elissa OzanneUniversity of Utah, Salt Lake City, UT, USA.
Sanja Percac-LimaMassachusetts General Hospital's Chelsea HealthCare Center, Chelsea, MA, USA.
Julia SongThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Jocelyn AcostaLaura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
Nageen MirDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Glyn ElwynThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
NCI NIH HHS P30 CA023108Patient-Centered Outcomes Research Institute CDR-1511-32975
6 · The paper itself

Abstract

backgroundBreast cancer is the most commonly diagnosed malignancy in women. Mastectomy and breast-conserving surgery (BCS) have equivalent survival for early stage breast cancer. However, each surgery has different benefits and harms that women may value differently. Women of lower socioeconomic status (SES) diagnosed with early stage breast cancer are more likely to experience poorer doctor-patient communication, lower satisfaction with surgery and decision-making, and higher decision regret compared to women of higher SES. They often play a more passive role in decision-making and are less likely to undergo BCS. Our aim is to understand how best to support women of lower SES in making decisions about early stage breast cancer treatments and to reduce disparities in decision quality across socioeconomic strata.

methodsWe will conduct a three-arm, multi-site randomized controlled superiority trial with stratification by SES and clinician-level randomization. At four large cancer centers in the United States, 1100 patients (half higher SES and half lower SES) will be randomized to: (1) Option Grid, (2) Picture Option Grid, or (3) usual care. Interviews, field-notes, and observations will be used to explore strategies that promote the interventions' sustained use and dissemination. Community-Based Participatory Research will be used throughout. We will include women aged at least 18 years of age with a confirmed diagnosis of early stage breast cancer (I to IIIA) from both higher and lower SES, provided they speak English, Spanish, or Mandarin Chinese. Our primary outcome measure is the 16-item validated Decision Quality Instrument. We will use a regression framework, mediation analyses, and multiple informants analysis. Heterogeneity of treatment effects analyses for SES, age, ethnicity, race, literacy, language, and study site will be performed. DISCUSSION: Currently, women of lower SES are more likely to make treatment decisions based on incomplete or uninformed preferences, potentially leading to poorer decision quality, quality of life, and decision regret. This study hopes to identify solutions that effectively improve patient-centered care across socioeconomic strata and reduce disparities in decision and care quality.

trial registrationNCT03136367 at ClinicalTrials.gov Protocol version: Manuscript based on study protocol version 2.2, 7 November 2017.

Indexed as

Decision Support TechniquesHealthcare DisparitiesPhysician-Patient RelationsSocial ClassAdultBreast NeoplasmsClinical ProtocolsCommunicationDecision MakingEmotionsFemaleHumansNeoplasm StagingPatient SatisfactionRisk AssessmentBreast cancer disparitiesBreast cancer surgeryDecision support techniquesEncounter decision aidsLow socioeconomic statusPicture superiority

Identifiers

PMID29439691
PMCPMC5812033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.